| 注册

重构本草——紫菀

李梦甜 乔丽萍 王昭博 杨李洋 王佳

长春中医药大学学报2025,Vol.41Issue(10):1080-1082,3.
长春中医药大学学报2025,Vol.41Issue(10):1080-1082,3.DOI:10.13463/j.cnki.cczyy.2025.10.005

重构本草——紫菀

Reconstruction of Chinese materia medica-tatarian aster root

李梦甜 1乔丽萍 2王昭博 3杨李洋 4王佳1

作者信息

  • 1. 中国中医科学院广安门医院综合科,北京 100053
  • 2. 南京中医药大学附属医院/江苏省中医院,南京 210029
  • 3. 中国中医科学院广安门医院内分泌科,北京 100053
  • 4. 中国中医科学院广安门医院综合科,北京 100053||北京中医药大学,北京 100029
  • 折叠

摘要

Abstract

Through investigation of ancient books and the sorting of modern research achievements of traditional Chinese medicine,combined with the understanding and application experience of famous experts and scholars in desciplinary fields such as traditional Chinese medicine clinical medicine and science of Chinese materia medica,it is concluded that tatarian aster root mainly has the effects of moistening the lung and descending qi,and eliminating phlegm and relieving cough.The symptom targets are cough,phlegm-induced asthma and constipation.Modern pharmacological studies have found that tatarian aster root and its active components have effects of relieving cough,eliminating phlegm,relieving asthma,and facilitating urination and defecation.Tatarian aster root has the relatively low toxicity,and its clinical application is safe and reliable,with no reported adverse reactions during its clinical use.Due to its pungent and warm properties,it may has the drawback of promoting the growth of heat pathogens and is therefore not suitable for patients with excessive heat syndrome.The commonly used clinical dosage is 5-30 g.

关键词

紫菀/症靶/重构本草/临床回归

Key words

tatarian aster root/symptom target/reconstruction of Chinese materia medica/clinical verification

分类

医药卫生

引用本文复制引用

李梦甜,乔丽萍,王昭博,杨李洋,王佳..重构本草——紫菀[J].长春中医药大学学报,2025,41(10):1080-1082,3.

基金项目

国家自然基金委-中国科学院联合项目资助中西医结合创新范式战略研究(XK2023SMC003) (XK2023SMC003)

中国中医科学院广安门医院临床医学研究中心建设专项培育项目(2022LYJSZX17) (2022LYJSZX17)

中央高水平中医医院临床科研业务费(HLCMHPP2023084) (HLCMHPP2023084)

长春中医药大学学报

2095-6258

访问量0
|
下载量0
段落导航相关论文